|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
14,410,000 |
Market
Cap: |
4.80(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.3333 - $0.3333 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-12-16 |
4 |
OE |
$2.50 |
$3,550,000 |
D/D |
1,420,000 |
4,000,452 |
|
- |
|
Keuer Thomas A |
Chief Operating Officer |
|
2022-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,730 |
|
- |
|
Dekker C. Jeffrey |
Chief Financial Officer |
|
2022-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
|
- |
|
Funicular Funds, Lp |
10% Owner |
|
2022-07-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,580,452 |
|
- |
|
Funicular Funds, Lp |
See Footnote 1 |
|
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,580,452 |
2,580,452 |
|
- |
|
Funicular Funds, Lp |
See Footnote 1 |
|
2022-07-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,580,452) |
2,580,452 |
|
- |
|
Ma-Weaver Jacob |
Director |
|
2022-06-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,580,452 |
|
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-05-25 |
4 |
B |
$2.32 |
$150,740 |
D/D |
64,851 |
2,580,452 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-05-24 |
4 |
B |
$2.29 |
$41,383 |
D/D |
18,110 |
2,515,601 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-05-23 |
4 |
B |
$2.30 |
$5,281 |
D/D |
2,301 |
2,497,491 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-05-19 |
4 |
B |
$2.25 |
$2 |
D/D |
1 |
2,495,190 |
2.36 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-05-18 |
4 |
B |
$2.30 |
$30,126 |
D/D |
13,072 |
2,495,189 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-05-16 |
4 |
B |
$2.30 |
$98,646 |
D/D |
42,914 |
2,482,117 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-05-13 |
4 |
B |
$2.29 |
$32,119 |
D/D |
14,000 |
2,439,203 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-05-12 |
4 |
B |
$2.27 |
$63,377 |
D/D |
27,922 |
2,425,203 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-05-11 |
4 |
B |
$2.29 |
$56,202 |
D/D |
24,596 |
2,397,281 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-05-10 |
4 |
B |
$2.28 |
$47,927 |
D/D |
20,979 |
2,372,685 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-05-09 |
4 |
B |
$2.27 |
$111,722 |
D/D |
49,221 |
2,351,706 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-05-06 |
4 |
B |
$2.28 |
$132,392 |
D/D |
57,998 |
2,302,485 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-05-05 |
4 |
B |
$2.27 |
$38,449 |
D/D |
16,903 |
2,244,487 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-05-02 |
4 |
B |
$2.32 |
$2,915 |
D/D |
1,259 |
2,227,584 |
2.36 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-04-29 |
4 |
B |
$2.30 |
$20,644 |
D/D |
8,974 |
2,226,325 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-04-28 |
4 |
B |
$2.32 |
$54,171 |
D/D |
23,381 |
2,217,351 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-04-25 |
4 |
B |
$2.29 |
$31,508 |
D/D |
13,751 |
2,193,970 |
2.44 |
- |
|
Ma-Weaver Jacob |
See Footnote 1 |
|
2022-04-18 |
4 |
B |
$2.31 |
$21,080 |
D/D |
9,119 |
2,180,219 |
2.44 |
- |
|
240 Records found
|
|
Page 1 of 10 |
|
|